Related Experiment Video
Updated: Oct 28, 2025
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Interventional Treatment for Cholangiocarcinoma
Hang Li1, Li Chen1, Guang-Yu Zhu1
1Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, China.
Cholangiocarcinoma (CCA) treatment advances focus on interventional therapies for unresectable cases. These methods offer palliative care, improving locoregional control and quality of life for liver cancer patients.
Area of Science:
- Hepatobiliary Malignancies
- Interventional Oncology
Background:
- Cholangiocarcinoma (CCA) is a significant primary liver cancer.
- Current classification includes intrahepatic and extrahepatic subtypes.
- Surgical resection is limited to less than half of CCA patients.
Purpose of the Study:
- To review recent advances in interventional treatments for unresectable CCA.
- To highlight future research directions in CCA management.
Main Methods:
- Review of interventional therapies including intra-arterial treatments, ablation, and brachytherapy (iodine-125 seed implantation).
Main Results:
- Interventional treatments provide acceptable palliative care for unresectable CCA.
- These therapies aid in locoregional control and symptom management.
Conclusions:
- Interventional oncology plays a crucial role in managing unresectable cholangiocarcinoma.
- Further research is needed to optimize these palliative strategies and improve patient outcomes.
More Related Videos
04:50Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
